Free Trial

STRATA Skin Sciences (SSKN) Competitors

STRATA Skin Sciences logo
$2.91 -0.05 (-1.69%)
As of 01/17/2025 03:59 PM Eastern

SSKN vs. LUCD, NTRB, BLAC, CLGN, OM, MODD, DXR, MBOT, MDAI, and NMTC

Should you be buying STRATA Skin Sciences stock or one of its competitors? The main competitors of STRATA Skin Sciences include Lucid Diagnostics (LUCD), Nutriband (NTRB), Bellevue Life Sciences Acquisition (BLAC), CollPlant Biotechnologies (CLGN), Outset Medical (OM), Modular Medical (MODD), Daxor (DXR), Microbot Medical (MBOT), Spectral AI (MDAI), and NeuroOne Medical Technologies (NMTC). These companies are all part of the "medical equipment" industry.

STRATA Skin Sciences vs.

Lucid Diagnostics (NASDAQ:LUCD) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

STRATA Skin Sciences has a net margin of -28.72% compared to Lucid Diagnostics' net margin of -1,069.87%. Lucid Diagnostics' return on equity of 0.00% beat STRATA Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Lucid Diagnostics-1,069.87% N/A -123.54%
STRATA Skin Sciences -28.72%-69.33%-17.55%

Lucid Diagnostics has a beta of 1.45, meaning that its stock price is 45% more volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500.

In the previous week, Lucid Diagnostics had 3 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 4 mentions for Lucid Diagnostics and 1 mentions for STRATA Skin Sciences. STRATA Skin Sciences' average media sentiment score of 1.00 beat Lucid Diagnostics' score of -0.25 indicating that STRATA Skin Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Lucid Diagnostics Neutral
STRATA Skin Sciences Positive

STRATA Skin Sciences has higher revenue and earnings than Lucid Diagnostics. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lucid Diagnostics$2.43M20.58-$52.67M-$1.14-0.74
STRATA Skin Sciences$32.68M0.37-$10.83M-$2.66-1.09

Lucid Diagnostics presently has a consensus price target of $3.63, suggesting a potential upside of 330.11%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, research analysts plainly believe Lucid Diagnostics is more favorable than STRATA Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lucid Diagnostics
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
STRATA Skin Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

STRATA Skin Sciences received 187 more outperform votes than Lucid Diagnostics when rated by MarketBeat users. However, 67.92% of users gave Lucid Diagnostics an outperform vote while only 63.90% of users gave STRATA Skin Sciences an outperform vote.

CompanyUnderperformOutperform
Lucid DiagnosticsOutperform Votes
36
67.92%
Underperform Votes
17
32.08%
STRATA Skin SciencesOutperform Votes
223
63.90%
Underperform Votes
126
36.10%

74.0% of Lucid Diagnostics shares are owned by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are owned by institutional investors. 8.8% of Lucid Diagnostics shares are owned by insiders. Comparatively, 39.0% of STRATA Skin Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Lucid Diagnostics beats STRATA Skin Sciences on 11 of the 18 factors compared between the two stocks.

Get STRATA Skin Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SSKN vs. The Competition

MetricSTRATA Skin SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$12.14M$4.57B$5.25B$8.92B
Dividend YieldN/A43.68%5.11%4.03%
P/E Ratio-1.0915.6261.8913.88
Price / Sales0.3759.811,215.8564.07
Price / CashN/A50.1443.8235.97
Price / Book0.807.795.324.79
Net Income-$10.83M$13.87M$122.69M$225.00M
7 Day Performance-1.36%1.46%-0.17%1.52%
1 Month Performance-4.59%12.36%3.49%4.88%
1 Year Performance-44.16%32.40%25.79%20.12%

STRATA Skin Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SSKN
STRATA Skin Sciences
2.291 of 5 stars
$2.91
-1.7%
N/A-46.8%$12.14M$32.68M-1.09120Short Interest ↓
Positive News
Gap Up
LUCD
Lucid Diagnostics
2.6636 of 5 stars
$0.82
-2.4%
$3.63
+343.4%
-41.5%$48.52M$4.19M-0.7270Short Interest ↑
Positive News
Gap Up
NTRB
Nutriband
N/A$4.25
+2.9%
N/A+54.0%$47.20M$2.02M-5.9910Positive News
Gap Up
BLAC
Bellevue Life Sciences Acquisition
N/A$11.35
flat
N/A+8.3%$45.87MN/A0.00N/APositive News
CLGN
CollPlant Biotechnologies
2.2483 of 5 stars
$4.00
-4.8%
$12.50
+212.5%
-23.8%$45.82M$650,000.00-2.6070Short Interest ↑
Positive News
OM
Outset Medical
2.9895 of 5 stars
$0.82
-11.1%
$4.50
+450.3%
-77.4%$42.97M$114.73M-0.30520
MODD
Modular Medical
2.3968 of 5 stars
$1.22
-7.6%
$5.00
+309.8%
-28.4%$42.32MN/A-1.9420Positive News
DXR
Daxor
3.1535 of 5 stars
$8.25
+0.4%
$24.75
+200.0%
-15.3%$39.93MN/A0.0037Short Interest ↑
MBOT
Microbot Medical
2.3877 of 5 stars
$1.82
-5.7%
$7.00
+284.6%
+22.4%$36.84MN/A-2.2720Short Interest ↑
Gap Down
MDAI
Spectral AI
2.3683 of 5 stars
$1.97
-10.5%
$4.50
+128.4%
-8.8%$36.62M$27.26M-3.0383Short Interest ↑
Gap Down
NMTC
NeuroOne Medical Technologies
0.5982 of 5 stars
$1.07
-5.4%
N/A-22.2%$33.00M$3.45M-2.2320Short Interest ↓
Gap Up

Related Companies and Tools


This page (NASDAQ:SSKN) was last updated on 1/19/2025 by MarketBeat.com Staff
From Our Partners